Molecular Imaging enters agreement with Dana-Farber to expand cancer cell lines

Multi-modality preclinical in-vivo imaging services provider Molecular Imaging (Ann Arbor, MI) has entered into a licensing agreement with Dana-Farber Cancer Institute (Boston, MA), which grants Molecular Imaging access to a substantial number of luciferase-enabled cancer cell lines developed at Dana-Farber. Now, Molecular Imaging has expanded ability to apply bioluminescent imaging technology to a broad array of cancer disease models, including expanded capability in various leukemias, multiple myeloma, triple-negative breast cancer, glioma, and melanoma.

Molecular Imaging will be collaborating with Andrew Kung, MD, Ph.D., and Scott Armstrong, MD, Ph.D., both of Dana-Farber, to further develop and make available these, and other cell lines, to improve the quantification and predictive power of bioluminescent imaging in cancer. The agreement gives Molecular Imaging access to over 100 additional luciferase-enabled cell lines, providing the ability to use imaging in a much broader array of cancer disease models, with greater confidence, says W. R. Leopold, Ph.D., VP of research and development at Molecular Imaging.

Kung is director of the Lurie Family Imaging Center at Dana-Farber and associate professor of pediatrics at Dana-Farber, Children's Hospital Boston and Harvard Medical School. Armstrong is also an associate professor of pediatrics at Dana-Farber, Children's Hospital Boston and Harvard Medical School and is co-director of both the Cancer Program/Harvard Stem Cell Institute and Dana-Farber/Harvard Cancer Center's Leukemia program.

-----

Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn

Follow OptoIQ on your iPhone; download the free app here.

Subscribe now to BioOptics World magazine; it's free!

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

Fluorescent jellyfish proteins light up unconventional laser

Safer lasers to map your cells could soon be in the offing -- all thanks to the humble jellyfish. Conventional lasers, like the pointer you might use to entertain your cat, produce light by emittin...

Fluorescence microscopy helps provide new insight into how cancer cells metastasize

By using fluorescence microscopy, scientists have discovered an alternate theory on how some cancer cells metastasize.

In vivo imaging method visualizes bone-resorbing cell function in real time

In vivo imaging can visualize sites where osteoclasts (bone-resorbing cells) were in the process of resorbing bone.

Flow cytometry analyzes cell population to predict cancer immunotherapy response

Flow cytometry helped find that the amount of white blood cells in melanoma tumors can predict response to a cancer therapy.

BLOGS

Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...

CONNECT WITH US

            

Twitter- BioOptics World

Copyright © 2007-2016. PennWell Corporation, Tulsa, OK. All Rights Reserved.PRIVACY POLICY | TERMS AND CONDITIONS